Ridloff Elena

CIK 00017725184 companiesWATERTOWN, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001772518

Recent Transactions

50 trades

Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2026-06-24+6,068→ 6,068 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-05-11$31.20/sh+3,000→ 3,000 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2026-05-11−3,000→ 13,000 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-05-11$87.00/sh−3,000→ 0 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-04-01$85.19/sh−3,400→ 1,200 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2026-04-01−4,600→ 0 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-04-01$14.18/sh+4,600→ 4,600 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-04-01$86.05/sh−1,200→ 0 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-03-31$14.18/sh+7,400→ 7,400 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2026-03-31−7,400→ 4,600 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-03-31$85.37/sh−7,400→ 0 total
Award
Sionna Therapeutics, Inc.$SION
Non-Qualified Stock Option (right to buy)
2026-01-02+165,440→ 165,440 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2025-09-02$25.08/sh−8,836→ 38,532 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2025-08-29$25.18/sh−748→ 47,368 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2025-08-28$25.97/sh−16,098→ 48,116 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2025-08-27$25.10/sh−3,618→ 64,214 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2025-08-26$25.13/sh−3,700→ 67,832 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2025-08-20$22.69/sh−17,500→ 71,532 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2025-08-19$21.08/sh−34,500→ 89,032 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-06-25+16,000→ 16,000 total
Disposition from Tender
Kronos Bio, Inc.
Common Stock
2025-06-20$0.57/sh−25,296→ 0 total
Disposition to Issuer
Kronos Bio, Inc.
Stock Option (Right to Buy)
2025-06-20−17,000→ 0 total
Disposition to Issuer
Kronos Bio, Inc.
Stock Option (Right to Buy)
2025-06-20−34,000→ 0 total
Disposition to Issuer
Kronos Bio, Inc.
Stock Option (Right to Buy)
2025-06-20−15,450→ 0 total
Disposition to Issuer
Kronos Bio, Inc.
Stock Option (Right to Buy)
2025-06-20−26,871→ 0 total
Disposition to Issuer
Kronos Bio, Inc.
Stock Option (Right to Buy)
2025-06-20−17,000→ 0 total
Disposition to Issuer
Kronos Bio, Inc.
Stock Option (Right to Buy)
2025-06-20−25,879→ 0 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-06-11−4,500→ 4,500 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-06-11$50.00/sh−4,500→ 0 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-06-11$20.29/sh+4,500→ 4,500 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-06-03$47.00/sh−4,800→ 0 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-06-03$45.50/sh−7,200→ 4,800 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-06-03−12,000→ 0 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-06-03$27.67/sh+12,000→ 12,000 total
Award
Sionna Therapeutics, Inc.$SION
Stock Option (Right to Buy)
2025-02-06+157,820→ 157,820 total
Award
Kronos Bio, Inc.
Common Stock
2024-06-25+11,333→ 25,296 total
Award
Kronos Bio, Inc.
Stock Option (Right to Buy)
2024-06-25+17,000→ 17,000 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2024-06-18+16,000→ 16,000 total
Award
Kronos Bio, Inc.
Stock Option (Right to Buy)
2023-06-22+17,000→ 17,000 total
Award
Kronos Bio, Inc.
Common Stock
2023-06-22+11,333→ 13,963 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2023-06-15+12,000→ 12,000 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2022-06-29+9,000→ 9,000 total
Award
Kronos Bio, Inc.
Stock Option (Right to Buy)
2022-06-22+34,000→ 34,000 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2022-06-15+12,000→ 12,000 total
Award
Kronos Bio, Inc.
Stock Option (Right to Buy)
2021-06-22+15,450→ 15,450 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2021-06-16+10,459→ 10,459 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2021-06-16+20,063→ 20,063 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2021-04-30$20.33/sh−1,032→ 10,553 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2021-04-29−3,245→ 6,491 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2021-04-29+3,245→ 11,585 total

Companies

Recent Filings

Address

C/O KYMERA THERAPEUTICS, INC. 500 NORTH BEACON STREET, 4TH FLOOR

WATERTOWN, MA, 02472

View on SEC.gov